SPMDvsXPH
SPDR Portfolio S&P 400 Mid Cap ETF against SPDR S&P Pharmaceuticals ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| SPMD | XPH | |
|---|---|---|
| Expense ratio | 0.030% | 0.35% |
| Assets | $18.4B | $487M |
| Net flow, 1 month | +$184M | −$69M |
| Net flow, 1 year | +$2B | +$254M |
| Return, YTD | +11.9% | +12.3% |
| Return, 1 year | +12.3% | +29.4% |
| Avg daily volume | 1.7M | 205K |
| Holdings | 401 | 41 |
| Listed | Nov 8, 2005 | Jun 19, 2006 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS